Inbunden, Engelska, 2026
Reframing Pharma through Global Health and Social Science
Evidence Ecologies
Del i serien Global Science Education
1018 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.
Beskrivning
This book explores how pharmaceutical evidence is designed, interpreted, and used, drawing on positivist, constructivist, critical realist, pragmatist, feminist, and decolonial traditions. It shows how dominant evidence paradigms often struggle to account for time, population heterogeneity, patient experience, and context across contemporary therapeutic and care settings.Rather than treating these dimensions as downstream complications, the book advances an evidence ecology approach—understanding evidence as an interacting system of methods, institutions, and social worlds—and offersa framework for aligning scientific rigor with access, uptake, and sustained therapeutic impact across diverse settings.• A conceptual framework showing how different philosophical positions influence evidence creation, interpretation, and governance.• A practical toolkit for translating those stances into study designs, evaluation metrics, and strategic decisionframeworks.• A bridge between academic reflection and professional application, enabling researchers, policymakers, and industry teams to align evidence with ethics, culture, and context.
Produktinformation
- Utgivningsdatum: 2026-04-24
- Mått: 138 x 216 x 15 mm
- Vikt: 500 g
- Format: Inbunden
- Språk: Engelska
- Serie: Global Science Education
- Antal sidor: 168
- Förlag: Taylor & Francis Ltd
- ISBN: 9781041326007
Utforska kategorier
Mer om författaren
Gregory Patrick Fagan, PhD, is a global health researcher whose work examines how pharmaceutical evidence is produced, interpreted, and governed within real-world health systems. Drawing on sociology, medical anthropology, and applied epistemic analysis, he studies how assumptions embedded in evidence design shape regulation, access, and therapeutic uptake across diverse settings. He has held senior roles in global health and rare disease programs and works at the intersection of pharmaceutical development, humanitarian access, and health systems.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.